137 related articles for article (PubMed ID: 32757748)
1. Development of a physiologically based pharmacokinetic model of diisononyl phthalate (DiNP) in pregnant rat and human.
Campbell JL; Otter R; Anderson WA; Longnecker MP; Clewell RA; North C; Clewell HJ
J Toxicol Environ Health A; 2020 Oct; 83(19-20):631-648. PubMed ID: 32757748
[TBL] [Abstract][Full Text] [Related]
2. Di-iso-nonylphthalate (DINP) metabolites in human urine after a single oral dose of deuterium-labelled DINP.
Koch HM; Angerer J
Int J Hyg Environ Health; 2007 Jan; 210(1):9-19. PubMed ID: 17182279
[TBL] [Abstract][Full Text] [Related]
3. Human urinary concentrations of monoisononyl phthalate estimated using physiologically based pharmacokinetic modeling and experimental pharmacokinetics in humanized-liver mice orally administered with diisononyl phthalate.
Miura T; Suemizu H; Goto M; Sakai N; Iwata H; Shimizu M; Yamazaki H
Xenobiotica; 2019 May; 49(5):513-520. PubMed ID: 29708805
[TBL] [Abstract][Full Text] [Related]
4. Oxidative metabolites of diisononyl phthalate as biomarkers for human exposure assessment.
Silva MJ; Reidy JA; Preau JL; Needham LL; Calafat AM
Environ Health Perspect; 2006 Aug; 114(8):1158-61. PubMed ID: 16882519
[TBL] [Abstract][Full Text] [Related]
5. Mono-(3-carboxypropyl) phthalate, a metabolite of di-n-octyl phthalate.
Calafat AM; Silva MJ; Reidy JA; Earl Gray L; Samandar E; Preau JL; Herbert AR; Needham LL
J Toxicol Environ Health A; 2006 Feb; 69(3-4):215-27. PubMed ID: 16263692
[TBL] [Abstract][Full Text] [Related]
6. Urinary biomarkers of di-isononyl phthalate in rats.
Silva MJ; Kato K; Wolf C; Samandar E; Silva SS; Gray EL; Needham LL; Calafat AM
Toxicology; 2006 Jun; 223(1-2):101-12. PubMed ID: 16697098
[TBL] [Abstract][Full Text] [Related]
7. The oral bioavailability of di-2-ethylhexyl phthalate (DEHP), di-isononyl phthalate (DiNP) and di-(isononyl)-cyclohexane-1,2-dicarboxylate (DINCH®) in house dust.
Plichta V; Völkel W; Fembacher L; Wöckner M; Nowak D; Fromme H
Toxicol Lett; 2022 Feb; 355():82-87. PubMed ID: 34801639
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and daily variation of phthalate metabolites in the urine of an adult population.
Fromme H; Bolte G; Koch HM; Angerer J; Boehmer S; Drexler H; Mayer R; Liebl B
Int J Hyg Environ Health; 2007 Jan; 210(1):21-33. PubMed ID: 17182278
[TBL] [Abstract][Full Text] [Related]
9. Urinary metabolites of diisodecyl phthalate in rats.
Kato K; Silva MJ; Wolf C; Gray LE; Needham LL; Calafat AM
Toxicology; 2007 Jul; 236(1-2):114-22. PubMed ID: 17499416
[TBL] [Abstract][Full Text] [Related]
10. The effects of the phthalate DiNP on reproduction†.
Yang S; Arcanjo RB; Nowak RA
Biol Reprod; 2021 Feb; 104(2):305-316. PubMed ID: 33125036
[TBL] [Abstract][Full Text] [Related]
11. Steady-State Human Pharmacokinetics of Monobutyl Phthalate Predicted by Physiologically Based Pharmacokinetic Modeling Using Single-Dose Data from Humanized-Liver Mice Orally Administered with Dibutyl Phthalate.
Miura T; Uehara S; Mizuno S; Yoshizawa M; Murayama N; Kamiya Y; Shimizu M; Suemizu H; Yamazaki H
Chem Res Toxicol; 2019 Feb; 32(2):333-340. PubMed ID: 30652481
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vivo hepatic effects of Di-isononyl phthalate (DINP) and related C7-C11 dialkyl phthalates on gap junctional intercellular communication (GJIC), peroxisomal beta-oxidation (PBOX), and DNA synthesis in rat and mouse liver.
Smith JH; Isenberg JS; Pugh G; Kamendulis LM; Ackley D; Lington AW; Klaunig JE
Toxicol Sci; 2000 Apr; 54(2):312-21. PubMed ID: 10774813
[TBL] [Abstract][Full Text] [Related]
13. Disposition of diiosononyl phthalate and its effects on sexual development of the male fetus following repeated dosing in pregnant rats.
Clewell RA; Sochaski M; Edwards K; Creasy DM; Willson G; Andersen ME
Reprod Toxicol; 2013 Jan; 35():56-69. PubMed ID: 22813627
[TBL] [Abstract][Full Text] [Related]
14. Subchronic Exposure to Di(2-ethylhexyl) Phthalate and Diisononyl Phthalate During Adulthood Has Immediate and Long-Term Reproductive Consequences in Female Mice.
Chiang C; Flaws JA
Toxicol Sci; 2019 Apr; 168(2):620-631. PubMed ID: 30649530
[TBL] [Abstract][Full Text] [Related]
15. Determination of secondary, oxidised di-iso-nonylphthalate (DINP) metabolites in human urine representative for the exposure to commercial DINP plasticizers.
Koch HM; Müller J; Angerer J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):114-25. PubMed ID: 17055785
[TBL] [Abstract][Full Text] [Related]
16. Trends of the internal phthalate exposure of young adults in Germany--follow-up of a retrospective human biomonitoring study.
Göen T; Dobler L; Koschorreck J; Müller J; Wiesmüller GA; Drexler H; Kolossa-Gehring M
Int J Hyg Environ Health; 2011 Dec; 215(1):36-45. PubMed ID: 21889907
[TBL] [Abstract][Full Text] [Related]
17. Prenatal phthalate exposures and anogenital distance in Swedish boys.
Bornehag CG; Carlstedt F; Jönsson BA; Lindh CH; Jensen TK; Bodin A; Jonsson C; Janson S; Swan SH
Environ Health Perspect; 2015 Jan; 123(1):101-7. PubMed ID: 25353625
[TBL] [Abstract][Full Text] [Related]
18. Predictability of human pharmacokinetics of diisononyl phthalate (DINP) using chimeric mice with humanized liver.
Iwata H; Goto M; Sakai N; Suemizu H; Yamazaki H
Xenobiotica; 2019 Nov; 49(11):1311-1322. PubMed ID: 30589368
[TBL] [Abstract][Full Text] [Related]
19. Biomonitoring equivalents for di-isononyl phthalate (DINP).
Hays SM; Aylward LL; Kirman CR; Krishnan K; Nong A
Regul Toxicol Pharmacol; 2011 Jul; 60(2):181-8. PubMed ID: 21466828
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of phthalate and DINCH® plasticizers, after oral administration of dust to piglets.
Plichta V; Völkel W; Fembacher L; Spolders M; Wöckner M; Aschenbrenner B; Schafft H; Fromme H
Toxicol Lett; 2019 Oct; 314():82-88. PubMed ID: 31306742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
